{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T02:43:59Z","timestamp":1722912239315},"reference-count":23,"publisher":"Medwave Estudios Limitada","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medwave"],"DOI":"10.5867\/medwave.2015.01.6065","type":"journal-article","created":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T12:48:48Z","timestamp":1421412528000},"page":"e6065-e6065","source":"Crossref","is-referenced-by-count":5,"title":["Antioxidant use as dietary therapy in patients with multiple sclerosis"],"prefix":"10.5867","volume":"15","author":[{"given":"Laura","family":"Gonz\u00e1lez-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas Giovanni","family":"P\u00e9rez-Cort\u00e9z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Flores-Aldana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayeli","family":"Mac\u00edas-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Hern\u00e1ndez-Gir\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3888","published-online":{"date-parts":[[2015,1,9]]},"reference":[{"issue":"6","key":"ref0","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2165\/00023210-200620060-00001","article-title":"Antioxidants in multiple sclerosis: do they have a role in therapy?","volume":"20","author":"Carlson","year":"2006","unstructured":"Carlson NG, Rose JW. Antioxidants in multiple sclerosis: do they have a role in therapy? CNS Drugs. 2006;20(6):433-41. | PubMed |","journal-title":"CNS Drugs","ISSN":"http:\/\/id.crossref.org\/issn\/1172-7047","issn-type":"print"},{"issue":"7","key":"ref1","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.clineuro.2010.03.029","article-title":"Nutrition in multiple sclerosis.","volume":"112","author":"Habek","year":"2010","unstructured":"Habek M, Hojsak I, Brinar VV. Nutrition in multiple sclerosis. Clin Neurol Neurosurg. 2010 Sep;112(7):616-20. | CrossRef | PubMed |","journal-title":"Clin Neurol Neurosurg","ISSN":"http:\/\/id.crossref.org\/issn\/0303-8467","issn-type":"print"},{"issue":"5","key":"ref2","first-page":"528","article-title":"Complementary and alternative medicine for the treatment of multiple sclerosis. Expert Rev Clin Immunol. 2010 May;6(3):381-95. | CrossRef | PubMed | Gonzalez O, Sotelo J. Is the frequency of multiple sclerosis increasing in Mexico? J Neurol Neurosurg Psychiatry. 1995 Nov;59(5):528-30. | PubMed | Link | Gonzalez O, Sotelo J. Is the frequency of multiple sclerosis increasing in Mexico?","volume":"59","author":"Yadav","year":"1995","unstructured":"Yadav V, Shinto L, Bourdette D. Complementary and alternative medicine for the treatment of multiple sclerosis. Expert Rev Clin Immunol. 2010 May;6(3):381-95. | CrossRef | PubMed | Gonzalez O, Sotelo J. Is the frequency of multiple sclerosis increasing in Mexico? J Neurol Neurosurg Psychiatry. 1995 Nov;59(5):528-30. | PubMed | Link | Gonzalez O, Sotelo J. Is the frequency of multiple sclerosis increasing in Mexico? J Neurol Neurosurg Psychiatry. 1995 Nov;59(5):528-30. | PubMed | Link |","journal-title":"J Neurol Neurosurg Psychiatry","ISSN":"http:\/\/id.crossref.org\/issn\/0022-3050","issn-type":"print"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1201\/NOE1850709466","author":"Poser","year":"1998","unstructured":"Poser CM. An atlas of multiple sclerosis. En: Multiple sclerosis. New York: Parthenon Publishing Group, 1998.","journal-title":"An atlas of multiple sclerosis En"},{"key":"ref4","unstructured":"Porras-Betancourt M, N\u00fa-ez-Orozco L, Plascencia-\u00c1lvarez NI, Qui-ones-Aguilar S, Sauri-Su\u00e1rez S. Esclerosis m\u00faltiple. Rev Mex Neuroci. 2007;8(1):57-66. | Link | Marrie RA, Wolfson C, Sturkenboom MC, Gout O, Heinzlef O, Roullet E, et al. Multiple sclerosis and antecedent infections: a case-control study. Neurology. 2000 Jun;54(12):2307-10. | PubMed | Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hern\u00e1n MA, Olek MJ, et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA. 2001 Dec;286(24):3083-8. | CrossRef | PubMed | Alvarez-Lafuente R, De las Heras V, Bartolom\u00e9 M, Picazo JJ, Arroyo R. Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. Arch Neurol. 2004 Oct;61(10):1523-7. | CrossRef | PubMed | Namaka M, Crook A, Doupe A, Kler K, Vasconcelos M, Klowak M, et al. Examining the evidence: complementary adjunctive therapies for multiple sclerosis. Neurol Res. 2008 Sep;30(7):710-9. | CrossRef | PubMed | Ebers GC. Prognostic factors for multiple sclerosis: the importance of natural history studies. J Neurol. 2005 Sep;252 Suppl 3:iii15-iii20. | PubMed | McAlpine D, Lumsden CE, Acheson ED. Multiple sclerosis: a reappraisal. Edinburgh: Livingstone, 1965."},{"issue":"3","key":"ref5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols.","volume":"13","author":"Poser","year":"1983","unstructured":"Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 Mar;13(3):227-31. | PubMed |","journal-title":"Ann Neurol","ISSN":"http:\/\/id.crossref.org\/issn\/0364-5134","issn-type":"print"},{"issue":"6","key":"ref6","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \"McDonald Criteria\".","volume":"58","author":"Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the \"McDonald Criteria\". Ann Neurol. 2005 Dec;58(6):840-6. | CrossRef | PubMed |","journal-title":"Ann Neurol","ISSN":"http:\/\/id.crossref.org\/issn\/0364-5134","issn-type":"print"},{"issue":"1-2","key":"ref7","first-page":"26","article-title":"Nutrition and diet in the clinical management of multiple sclerosis.J Hum Nutr Diet. 2001 Oct;14(5):349-57. | CrossRef | PubMed | Oxilia R. Estr\u00e9s oxidativo y sistema de defensa antioxidante. R Rev Inst Med Trop. 2010;5(2):23-29 | Link | Mirshafiey A, Mohsenzadegan M. Antioxidant therapy in multiple sclerosis. Immunopharmacol Immunotoxicol. 2009;31(1):13-29. | CrossRef | PubMed | Miller E, Walczak A, Saluk J, Ponczek MB, Majsterek I. Oxidative modification of patient's plasma proteins and its role in pathogenesis of multiple sclerosis.","volume":"45","author":"Payne","year":"2012","unstructured":"Payne A. Nutrition and diet in the clinical management of multiple sclerosis.J Hum Nutr Diet. 2001 Oct;14(5):349-57. | CrossRef | PubMed | Oxilia R. Estr\u00e9s oxidativo y sistema de defensa antioxidante. R Rev Inst Med Trop. 2010;5(2):23-29 | Link | Mirshafiey A, Mohsenzadegan M. Antioxidant therapy in multiple sclerosis. Immunopharmacol Immunotoxicol. 2009;31(1):13-29. | CrossRef | PubMed | Miller E, Walczak A, Saluk J, Ponczek MB, Majsterek I. Oxidative modification of patient's plasma proteins and its role in pathogenesis of multiple sclerosis. Clin Biochem. 2012 Jan;45(1-2):26-30. | CrossRef | PubMed |","journal-title":"Clin Biochem","ISSN":"http:\/\/id.crossref.org\/issn\/0009-9120","issn-type":"print"},{"issue":"2","key":"ref8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1191\/1352458505ms1143oa","article-title":"Lipoic acid in multiple sclerosis: a pilot study.","volume":"11","author":"Yadav","year":"2005","unstructured":"Yadav V, Marracci G, Lovera J, Woodward W, Bogardus K, Marquardt W, et al. Lipoic acid in multiple sclerosis: a pilot study. Mult Scler. 2005 Apr;11(2):159-65. | PubMed |","journal-title":"Mult Scler","ISSN":"http:\/\/id.crossref.org\/issn\/1352-4585","issn-type":"print"},{"issue":"5","key":"ref9","first-page":"727","article-title":"Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling. PLoS One. 2010 Sep;5(9). pii: e13058. | CrossRef | PubMed | Marracci GH, Jones RE, McKeon GP, Bourdette DN. Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis. J Neuroimmunol. 2002 Oct;131(1-2):104-14. | CrossRef | PubMed | Manach C, Scalbert A, Morand C, R\u00e9m\u00e9sy C, Jim\u00e9nez L. Polyphenols: food sources and bioavailability.","volume":"79","author":"Salinthone","year":"2004","unstructured":"Salinthone S, Yadav V, Schillace RV, Bourdette DN, Carr DW. Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling. PLoS One. 2010 Sep;5(9). pii: e13058. | CrossRef | PubMed | Marracci GH, Jones RE, McKeon GP, Bourdette DN. Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis. J Neuroimmunol. 2002 Oct;131(1-2):104-14. | CrossRef | PubMed | Manach C, Scalbert A, Morand C, R\u00e9m\u00e9sy C, Jim\u00e9nez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004 May;79(5):727-47. | PubMed | Link |","journal-title":"Am J Clin Nutr","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9165","issn-type":"print"},{"issue":"4","key":"ref10","first-page":"538","article-title":"Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis. J Neuroimmunol. 2002 Oct;131(1-2):104-14. | CrossRef | PubMed | Jones RE, Moes N, Zwickey H, Cunningham CL, Gregory WL, Oken B. Treatment of experimental autoimmune encephalomyelitis with alpha lipoic acid and associative conditioning.","volume":"22","author":"Marracci","year":"2008","unstructured":"Marracci GH, Jones RE, McKeon GP, Bourdette DN. Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis. J Neuroimmunol. 2002 Oct;131(1-2):104-14. | CrossRef | PubMed | Jones RE, Moes N, Zwickey H, Cunningham CL, Gregory WL, Oken B. Treatment of experimental autoimmune encephalomyelitis with alpha lipoic acid and associative conditioning. Brain Behav Immun. 2008 May;22(4):538-43. | CrossRef | PubMed |","journal-title":"Brain Behav Immun","ISSN":"http:\/\/id.crossref.org\/issn\/0889-1591","issn-type":"print"},{"issue":"12","key":"ref11","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/sj.ejcn.1602255","article-title":"Antioxidants and polyunsaturated fatty acids in multiple sclerosis.","volume":"59","author":"van Meeteren","year":"2005","unstructured":"van Meeteren ME, Teunissen CE, Dijkstra CD, van Tol EA. Antioxidants and polyunsaturated fatty acids in multiple sclerosis. Eur J Clin Nutr. 2005 Dec;59(12):1347-61. | CrossRef | PubMed |","journal-title":"Eur J Clin Nutr","ISSN":"http:\/\/id.crossref.org\/issn\/0954-3007","issn-type":"print"},{"issue":"5","key":"ref12","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.bcp.2003.10.018","article-title":"Dietary compounds prevent oxidative damage and nitric oxide production by cells involved in demyelinating disease.","volume":"67","author":"van Meeteren","year":"2004","unstructured":"van Meeteren ME, Hendriks JJ, Dijkstra CD, van Tol EA. Dietary compounds prevent oxidative damage and nitric oxide production by cells involved in demyelinating disease. Biochem Pharmacol. 2004 Mar 1;67(5):967-75. | PubMed |","journal-title":"Biochem Pharmacol","ISSN":"http:\/\/id.crossref.org\/issn\/0006-2952","issn-type":"print"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S0076-6879(99)01113-1","article-title":"Assay of inducible form of nitric oxide synthase activity: effect of flavonoids and plant extracts.","volume":"301","author":"Kobuchi","year":"1999","unstructured":"Kobuchi H, Virgili F, Packer L. Assay of inducible form of nitric oxide synthase activity: effect of flavonoids and plant extracts. Methods Enzymol. 1999;301:504-13. | PubMed |","journal-title":"Methods Enzymol","ISSN":"http:\/\/id.crossref.org\/issn\/0076-6879","issn-type":"print"},{"issue":"5","key":"ref14","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1177\/1403494813481646","article-title":"Differences between users and non-users of complementary and alternative medicine among people with multiple sclerosis in Denmark: a comparison of descriptive characteristics.","volume":"41","author":"Skovgaard","year":"2013","unstructured":"Skovgaard L, Nicolajsen PH, Pedersen E, Kant M, Fredrikson S, Verhoef M, et al. Differences between users and non-users of complementary and alternative medicine among people with multiple sclerosis in Denmark: a comparison of descriptive characteristics. Scand J Public Health. 2013 Jul;41(5):492-9. | CrossRef | PubMed |","journal-title":"Scand J Public Health","ISSN":"http:\/\/id.crossref.org\/issn\/1403-4948","issn-type":"print"},{"issue":"4","key":"ref15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4103\/0972-2327.104328","article-title":"The therapeutic value of yoga in neurological disorders.","volume":"15","author":"Mishra","year":"2012","unstructured":"Mishra SK, Singh P, Bunch SJ, Zhang R. The therapeutic value of yoga in neurological disorders. Ann Indian Acad Neurol. 2012 Oct;15(4):247-54. | CrossRef | PubMed |","journal-title":"Ann Indian Acad Neurol","ISSN":"http:\/\/id.crossref.org\/issn\/0972-2327","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1472-6882-12-209","article-title":"Impact of electroacupuncture on quality of life for patients with Relapsing-Remitting Multiple Sclerosis under treatment with immunomodulators: a randomized study.","volume":"12","year":"2012","unstructured":"Quispe-Cabanillas JG1, Damasceno A, von Glehn F, Brand\u00e3o CO, Damasceno BP, Silveira WD, et al. Impact of electroacupuncture on quality of life for patients with Relapsing-Remitting Multiple Sclerosis under treatment with immunomodulators: a randomized study. BMC Complement Altern Med. 2012 Nov 5;12:209. | CrossRef | PubMed |","journal-title":"BMC Complement Altern Med","ISSN":"http:\/\/id.crossref.org\/issn\/1472-6882","issn-type":"print"},{"issue":"1","key":"ref17","first-page":"22","article-title":"Use of therapies other than disease-modifying agents, including complementary and alternative medicine, by patients with multiple sclerosis: a survey study.","volume":"112","author":"Stoll","year":"2012","unstructured":"Stoll SS, Nieves C, Tabby DS, Schwartzman R. Use of therapies other than disease-modifying agents, including complementary and alternative medicine, by patients with multiple sclerosis: a survey study. J Am Osteopath Assoc. 2012 Jan;112(1):22-8. | PubMed |","journal-title":"J Am Osteopath Assoc","ISSN":"http:\/\/id.crossref.org\/issn\/0098-6151","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Skovgaard L, Nicolajsen PH, Pedersen E, Kant M, Fredrikson S, Verhoef M, et al. Use of complementary and alternative medicine among people with multiple sclerosis in the nordic countries. Autoimmune Dis. 2012;2012:841085. | CrossRef | PubMed |","DOI":"10.1155\/2012\/841085"},{"issue":"8","key":"ref19","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1177\/1352458508092808","article-title":"Complementary and alternative medicine for multiple sclerosis.","volume":"14","author":"Schwarz","year":"2008","unstructured":"Schwarz S, Knorr C, Geiger H, Flachenecker P. Complementary and alternative medicine for multiple sclerosis. Mult Scler. 2008 Sep;14(8):1113-9. | CrossRef | PubMed |","journal-title":"Mult Scler","ISSN":"http:\/\/id.crossref.org\/issn\/1352-4585","issn-type":"print"},{"issue":"3","key":"ref20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/1028415031000115945","volume":"6","author":"Shinto","year":"2003","unstructured":"Shinto L, Yadav V, Morris C, Lapidus JA, Senders A, Bourdette D. Demographic and health-related factors associated with complementary and alternative medicine (CAM) use in multiple sclerosis. Mult Scler. 2006 Feb;12(1):94-100. | CrossRef | PubMed | Bowling AC, Stewart TM. Current Complementary and Alternative Therapies for Multiple Sclerosis. Curr Treat Options Neurol. 2003 Jan;5(1):55-68. | PubMed | Doctrow SR1, Huffman K, Marcus CB, Musleh W, Bruce A, Baudry M, et al. Salen-manganese complexes: combined superoxide dismutase\/catalase mimics with broad pharmacological efficacy. Adv Pharmacol. 1997;38:247-69. | PubMed | Jim\u00e9nez-Jim\u00e9nez FJ, de Bustos F, Molina JA, de Andr\u00e9s C, Gasalla T, Ort\u00ed-Pareja M, et al. Cerebrospinal fluid levels of alpha-tocopherol in patients with multiple sclerosis. Neurosci Lett. 1998 Jun 12;249(1):65-7. | CrossRef | PubMed | Dworkin RH, Bates D, Millar JH, Paty DW. Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials. Neurology. 1984 Nov;34(11):1441-5. | PubMed | Apel A, Greim B, Zettl UK. How frequently do patients with multiple sclerosis use complementary and alternative medicine? Complement Ther Med. 2005 Dec;13(4):258-63. | CrossRef | PubMed | Mart\u00edn PA. Esclerosis M\u00faltiple y h\u00e1bitos alimentarios en Canarias. [Tesis de doctorado]. Facultad de medicina, Universidad de las Palmas de gran Canaria, Espa-a, 2010. Besler HT1, Como\u011flu S. Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis. Nutr Neurosci. 2003 Jun;6(3):189-96. | CrossRef | PubMed |","journal-title":"Nutr Neurosci","ISSN":"http:\/\/id.crossref.org\/issn\/1028-415X","issn-type":"print"},{"issue":"1-2","key":"ref21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jneuroim.2008.05.003","article-title":"Lipoic acid stimulates cAMP production via the EP2 and EP4 prostanoid receptors and inhibits IFN gamma synthesis and cellular cytotoxicity in NK cells.","volume":"199","author":"Salinthone","year":"2008","unstructured":"Salinthone S, Schillace RV, Marracci GH, Bourdette DN, Carr DW. Lipoic acid stimulates cAMP production via the EP2 and EP4 prostanoid receptors and inhibits IFN gamma synthesis and cellular cytotoxicity in NK cells. J Neuroimmunol. 2008 Aug;199(1-2):46-55. | CrossRef | PubMed |","journal-title":"J Neuroimmunol","ISSN":"http:\/\/id.crossref.org\/issn\/0165-5728","issn-type":"print"},{"issue":"6","key":"ref22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.nutres.2010.06.009","article-title":"Alpha-Lipoic acid reduces matrix metalloproteinase activity in MDA-MB-231 human breast cancer cells.","volume":"30","author":"Lee","year":"2010","unstructured":"Lee HS, Na MH, Kim WK. Alpha-Lipoic acid reduces matrix metalloproteinase activity in MDA-MB-231 human breast cancer cells. Nutr Res. 2010 Jun;30(6):403-9. | CrossRef | PubMed |","journal-title":"Nutr Res","ISSN":"http:\/\/id.crossref.org\/issn\/0271-5317","issn-type":"print"}],"container-title":["Medwave"],"original-title":["Uso de antioxidantes como terapia diet\u00e9tica en pacientes con esclerosis m\u00faltiple"],"link":[{"URL":"https:\/\/www.medwave.cl\/link.cgi\/Medwave\/Revisiones\/RevisionClinica\/6065","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T15:57:07Z","timestamp":1566230227000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medwave.cl\/link.cgi\/Medwave\/Revisiones\/6065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,9]]},"references-count":23,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2015,1,9]]}},"URL":"https:\/\/doi.org\/10.5867\/medwave.2015.01.6065","relation":{},"ISSN":["0717-6384"],"issn-type":[{"value":"0717-6384","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,9]]}}}